原发性蛛网膜下腔出血3种用药方案成本-效果分析

Three Therapeutic Schemes for Primary Subarachnoid Hemorrhage:Cost-effectiveness Analysis

目的:对治疗原发性蛛网膜下腔出血的3种用药方案进行疗效及成本-效果比较,以期寻找最佳治疗方案。方法:对本院各科室收治的108例原发性蛛网膜下腔出血患者用成本-效果分析法及比较有效率的方法进行综合评价。结果:使用抗纤溶药组治疗效果显著优于另外两组,但各组成本-效果比无明显差异。结论:使用抗纤溶药是保守治疗原发性蛛网膜下腔出血的最佳方案。

OBJECTIVE： To seek for the best therapy for Subarachnoid hemorrhage by comparing the cost - effectiveness among three therapeutic schemes. METHODS： The cost - effectiveness and effective rates of three therapeutic schemes for 108 patients with subarachnoid hemorrhage were evaluated comprehensively. RESULTS： The therapeutic efficacy in patients receiving anti- plasmin was significantly higher than in the other two groups, but there were no significant differences in cost - effectiveness ratio among the 3 groups. CONCLUSION： Anti - plasmin has been proved to be the optimal therapy for primary subarachnoid hemorrhage.